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T helper (Th) cells are critical for defenses against
infection and recognize peptides bound to class II
major histocompatibility complex (MHC II) mole-
cules. Although transcription factors have been iden-
tified that direct Th cells into specific effector fates,
whether a ‘‘master’’ regulator controls the develop-
mental program common to all Th cells remains
unclear. Here, we showed that the two transcription
factors Thpok and LRF share this function. Although
disruption of both factors did not prevent the gener-
ation of MHC II-specific T cells, these cells failed to
express Th cell genes or undergo Th cell differentia-
tion in vivo. In contrast, T cells lacking Thpok, which
only displayed LRF-dependent functions, contrib-
uted to multiple effector responses, both in vitro
and in vivo, with the notable exception of Th2 cell
responses that control extracellular parasites. These
findings identify the Thpok-LRF pair as a core node
of Th cell differentiation and function.
INTRODUCTION
T helper (Th) cells control the function of most immune cells and
are critical for defenses against infections and immune homeo-
stasis (Paul, 2008). They recognize peptides bound to class II
major histocompatibility complex (MHC II) molecules and
express the CD4 ‘‘coreceptor’’ for MHC II, contrasting with cyto-
toxic T cells, which are MHC I restricted and express the CD8
coreceptor for MHC I. Unlike the relative uniformity of cytotoxic
effector differentiation, the ‘‘helper program’’ is multifaceted.
Multiple subtypes of Th effector cells have been identified, on
the basis of cytokine production patterns; these include cells
producing the cytokines IFN-g (Th1), IL-4, IL-5, and IL-13
(Th2), or IL-17 (Th17), in addition to regulatory T (Treg) cells622 Immunity 37, 622–633, October 19, 2012 ª2012 Elsevier Inc.that negatively control immune responses (Zhu et al., 2010;
O’Shea and Paul, 2010). However, despite such diversity,
a few core markers characterize Th cells and show little or no
expression in CD8+ cells (Xiong and Bosselut, 2011); these
include CD4 itself, whose expression is epigenetically silenced
in CD8+ T cells (Zou et al., 2001), CD40L, a molecule essential
for help to dendritic cells and B cells (Quezada et al., 2004),
and the zinc finger transcription factor Thpok (He et al., 2005;
Sun et al., 2005).
Which transcriptional programs underpin such functional
differences between CD4+ and CD8+ T cells remains unknown.
Most of the ‘‘master regulatory’’ transcription factors that direct
Th effector cell differentiation, including Gata3 for Th2 cells,
T-bet for Th1, and RORgt for Th17, are specifically upregulated
in the corresponding effector subtype, but show little or no
expression in naive CD4+ cells (Zhu et al., 2010; O’Shea and
Paul, 2010). Preprogramming for helper or cytotoxic function
occurs in the thymus, during the divergence of CD4 helper and
CD8 cytotoxic lineages, defined by the termination of either
coreceptor expression after the CD4+CD8+ ‘‘double positive’’
(DP) stage (Corbella et al., 1994; Matechak et al., 1996). Conse-
quently, it is thought that the same transcriptional program
directs both functional preprogramming and coreceptor expres-
sion. There is evidence that this is the case in the CD8+ T cell
lineage, given that the transcription factor Runx3 both represses
Cd4 and promotes cytotoxic gene expression (Taniuchi et al.,
2002; Woolf et al., 2003; Wang et al., 2008a; Cruz-Guilloty
et al., 2009). However, which factor(s) preprogram for Th cell
functions has not been determined.
The zinc finger transcription factor Thpok (He et al., 2005; Sun
et al., 2005) was proposed to serve such a function because in its
absence, MHC II-restricted precursors differentiate into CD8+
T cells instead of their normal CD4+ fate (He et al., 2005). Such
‘‘redirected’’ CD8+ Thpok-deficient cells express the cytotoxic
marker perforin and were therefore proposed to undergo cyto-
toxic differentiation. However, possibly because their expression
of the CD8 coreceptor does not match their MHC II specificity,
their Th cell potential has not been analyzed so far.
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Thpok and LRF Promote Helper T Cell DifferentiationThe present study started with the striking observation that
Thpok-deficient MHC II-restricted cells re-express CD4 upon
activation, therefore reconstituting a matched TCR-coreceptor
pair for MHC binding and raising the obvious question of their
effector potential. We show that, unexpectedly, these cells retain
key Th cell attributes. They contribute to multiple effector
responses, both in vitro and in vivo, with the notable exception
of Th2 cell differentiation that was inhibited by their expression
of the CD8-differentiating factor Runx3. Such Thpok-indepen-
dent Th cell functions require the Thpok-related transcription
factor LRF, identifying a two-component control of T cell function
by transcription factors of the Thpok family.
RESULTS
Expression of Th Cell Genes in Redirected
Thpok-Deficient Cells
We first characterized peripheral T cells in mice lacking Zbtb7b,
the gene encoding Thpok (Wang et al., 2008b). As previously
reported (He et al., 2005), Thpok is required for MHC II-restricted
cells to adopt their normal CD4+CD8–expression pattern:
Zbtb7b–/– mice had very few CD4+ T cells (Figure S1A available
online), and most Zbtb7b–/– MHC II-restricted cells were
CD4–CD8+ and expressed cytotoxic markers (Figures 1A and
S1B and data not shown). Using an MHC II-tetramer-based
assay identifying antigen-specific cells in the naive repertoire
(Moon et al., 2007), we found similar numbers of cells recog-
nizing defined MHC II-peptide complexes in Thpok-sufficient
and -deficient mice (Figure 1B and data not shown). These cells
were CD4+ in the former and CD8+ in the latter, and in both cases
had low expression of thememorymarker CD44, a characteristic
of naive T cells. These findings indicate that, despite their mis-
matched MHC specificity and coreceptor expression, Thpok-
deficient cells have an antigenic repertoire similar to that of their
wild-type counterparts.
In addition to these naive CD4–CD8+ cells, Thpok-deficient
spleens also contained small populations of CD4-expressing
cells (CD4+CD8+ and CD4+CD8–) (Figure 1A). Unlike their
CD4–CD8+ counterparts, these cells expressed high amounts
of CD44, a feature typical of antigen-experienced T cells (data
not shown). This raised the possibility that Thpok was dispens-
able for CD4 expression in antigen-activated cells. Indeed,
purified Thpok-deficient ‘‘redirected’’ CD8+ splenocytes (MHC
II-restricted, sorted CD4–CD8+) re-expressed CD4 when acti-
vated through their antigen receptor in vitro (Figures 1C and
S1C). This was unlike MHC I-restricted CD8+ cells, which epige-
netically silence Cd4 (Zou et al., 2001). Of note, Thpok-deficient
cells that re-expressed CD4 nonetheless expressed the tran-
scription factor Runx3, which is normally produced in CD8+ cells
and promotes Cd4 silencing during their differentiation (Taniuchi
et al., 2002; Woolf et al., 2003) (Figure 1D). Upon activation, re-
directed Thpok-deficient cells also expressed CD40L, a CD4+
T cell lineage molecule required for help to dendritic cells and
B cells and for in vivo effector responses (Quezada et al.,
2004) (Figure 1E). The distinctive gene expression of redirected
cells was associated with the deposition of lysine 4-trimethy-
lated histone H3 (H3K4Me3), a mark characteristic of genes
actively transcribed or poised for expression (Barski et al.,
2007) at characteristic Th cell genes; these included Cd40lg,the Zbtb7b locus itself, Ctla4, and Ly6a, although not Cd4
(Figure 1F).
Thpok and LRFPromote ThCell GeneExpression In Vitro
These findings suggested that another transcription factor
promoted Th cell gene expression in Thpok-deficient cells, and
we considered the possibility that this factor could be Thpok
related. Of the two genesmost closely related to Zbtb7b, namely
Zbtb7a and Zbtb7c (Figure S2A), only the former, encoding the
transcription factor LRF (Davies et al., 1999), is expressed during
T cell differentiation (Maeda et al., 2007) (data from the Immgen
database [Heng and Painter, 2008], and data not shown). Intra-
cellular staining detected LRF protein in CD4+ and CD8+ SP
thymocytes and T cells andmuch lower expression in DP thymo-
cytes (Figures 2A and S2B); this pattern contrasted with Thpok
whose expression is limited to CD4+ T cells (He et al., 2005;
Sun et al., 2005). Given the pleiotropic effects of LRF on mouse
development (Maeda et al., 2007), we used Cd4-Cre mediated
disruption to inactivate Zbtb7a and Zbtb7b in T cells. Although
Cd4-Cre deletion of Zbtb7a efficiently disrupted LRF protein
expression (Figure S2B), it did not detectably affect CD4+
T cell differentiation and expression of Th cell genes (Figures
S3A–S3E). As expected, Cd4-Cre disruption of Zbtb7b phe-
nocopied the T cell developmental defects of germline deletion
(data not shown).
We followed the fate of MHC II-restricted precursors double
deficient for Thpok and LRF in B2m–/– Zbtb7bfl/fl Zbtb7afl/fl
Cd4-Cremice, hereafter called ‘‘double deficient,’’ in which b2m
disruption prevents MHC I expression. These cells were redir-
ected into the CD8+ T cell lineage and became mature CD8 SP
thymocytes and T cells, similar to their Thpok-deficient counter-
parts, despite efficient LRF disruption (Figures 2B, 2C, and S4A).
Their Runx3 expression was similar to that of Thpok-deficient
cells (Figure S4B). However, the CD4+CD8+ subset character-
istic of Thpok-deficient animals was absent. Although there
were CD4+CD8– cells in the spleen of double-deficient mice (Fig-
ure 2C), these cells were CD44hi and retained floxed Zbtb7b
alleles (Figures S4C and S4D), suggesting that they resulted
from the proliferation, possibly induced by environmental anti-
gens, of small numbers of precursors that had not undergone
deletion. If that interpretation were correct, these cells would
not expand in the presence of wild-type competitors. To verify
this, we generated mixed bone marrow chimeras by reconstitut-
ing lethally irradiated recipients with a mix of double-deficient
and wild-type progenitors that can be distinguished by CD45
allelism (Figure 2D, left). Although double-deficient cells effi-
ciently contributed to spleen T cell populations, they did not
give rise to any CD4+CD8– or CD4+CD8+ cells (Figure 2D, right),
supporting the idea that disruption of Thpok and LRF resulted in
a complete lack of CD4+ T cell differentiation.
Accordingly, double-deficient splenocytes did not re-express
CD4 in vitro (Figure 3A) and failed to express CD40L, similar to
wild-type (MHC I-restricted) CD8+ cells (Figure 3B, top). These
functional defects could be tracked to the thymus, where
double-deficient CD8 SP cells expressed little CD40L, con-
trasting with Thpok-deficient CD8 SP or wild-type CD4 SP
thymocytes (Lesley et al., 2006) (Figure 3B, bottom). Thus,
expression of Th cell markers in Thpok-deficient cells is LRF-
dependent.Immunity 37, 622–633, October 19, 2012 ª2012 Elsevier Inc. 623
Figure 1. Thpok Is Dispensable for Th Cell Differentiation
(A) Contour plots show CD4 versus CD8 expression on TCRb+ splenocytes from Zbtb7b+/+B2m–/– and Zbtb7b–/– B2m–/– mice (top) and numbers of spleen T cells
in each strain (bottom).
(B) Contour plots are gated on CD4+ or CD8+ cells obtained from Zbtb7b+/+ and Zbtb7b–/– mice and enriched on a 2W-I-Ab tetramer column and show tetramer
versus CD44 staining. Between parenthesis (right) are absolute numbers of tetramer binding cells per mouse in outlined gates.
Immunity
Thpok and LRF Promote Helper T Cell Differentiation
624 Immunity 37, 622–633, October 19, 2012 ª2012 Elsevier Inc.
A B
C D
Figure 2. LRF Expression and Function in T Cell Development
(A) Histogram plots of LRF protein expression in wild-type DP, CD4 SP, and CD8 SP thymocytes (top) and CD4+ and CD8+ splenocytes (bottom); gray-filled
histograms indicate background fluorescence (no LRF staining) in DP thymocytes.
(B) CD4 versus CD8 contour plots on all live (top) and mature (TCRbhi CD24lo, bottom) thymocytes from control, Thpok-deficient, or Thpok and LRF (Zbtb7bfl/fl
Zbtb7afl/fl Cd4-Cre) double-deficient animals.
(C) Contour plots (top) show CD4 versus CD8 expression on TCRb+ splenocytes from the same mice as in (B). Bottom plots show numbers of cells in indicated
populations of Thpok- (filled circles) and double-deficient (filled squares) mice. Bars indicate average ± SEM. In (A)–(C), data are representative of at least three
experiments.
(D) Lethally irradiated CD45.1 wild-type mice were reconstituted with a 1:1 mix of wild-type CD45.1 and either Thpok-LRF double-deficient or control CD45.2
bone marrow (left schematic). Contour plots of CD45.2 versus CD45.1 on gated T cells (TCRb+ I-A/I-E–) define donor- versus competitor-derived populations
8 weeks after reconstitution. T cells were further analyzed for CD4 and CD8 expression (bottom). Numbers in boxes represent percent of cells. Data are
representative of two separate transplantation experiments, totaling three sets of double deficient and two sets of control donors (at least three recipients per set).
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To compare the contributions of Thpok and LRF to Th cell differ-
entiation in vivo, we interrogated T cell populations in the small
intestine lamina propria (siLP), in which effector and regulatory(C) Contour plots show CD4 versus CD8 expression on Th2-activated effectors o
LN and splenic cells; the purity of each sorted population is shown in Figure S1C
(D) Plain line histograms show tomato-red fluorescent protein (tRFP) signal in a
carrying a tRFPBAC transgene (Runx3tRFP) that tracksRunx3 expression (Zamisch
cells and gray-filled histograms background fluorescence in the corresponding s
(E) Contour plot show CD69 versus CD40L expression after 3 hr activation of Zbt
TCRb+ CD4+ or CD8+ cells as indicated.
(F) Plots depict the distribution of H3K4Me3 along relevant CD4+ T cell lineage ge
cells (both Zbtb7b+/+) and redirected Zbtb7b–/–MHC II-restricted CD8 cells. Bars r
locus; genes are schematically depicted at the top of each graph. The same verti
within the locus. Data are representative of two (B and F) or at least three experiresponsesdevelop in unmanipulatedmice as a result of exposure
to commensal and food antigens (Agace, 2008). Most wild-type
siLP T cells are MHC II-restricted CD44hi effectors and normally
CD4+. In contrast, the siLP of Thpok-deficient mice containedbtained from sorted naive (CD44lo) CD4–CD8+ Zbtb7b+/+ and Zbtb7b–/– B2m–/–
.
ctivated Zbtb7b–/– TCRb+CD4+CD8+ cells (top) and CD8+CD4– cells (bottom)
et al., 2009). Dashed lines show tRFP fluorescence in activated Zbtb7b+/+ CD8
ubset from a ‘‘reporterless’’ mouse.
b7b+/+, Zbtb7b–/–B2m–/–, and Zbtb7b–/– H2-Ab1–/– LN cells; data are gated on
nes, as obtained from H3K4Me3 Chipseq analyses of wild-type CD4 and CD8
epresent normalized H3K4Me3 signal in sequential 200 bpwindows along each
cal scale was used for all plots. Numbers indicate cumulative H3K4Me3 signal
ments (A and C–E).
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Figure 3. LRF Promotes Th Cell Gene Expression
(A) Contour plots of CD4 versus CD8 expression on effectors obtained 4 days after activation of sorted naive (CD44lo) CD4–CD8+ T cells from the indicated mice;
scatter plots on the bottom summarized data from four experiments (triangles, wild-type; circles, Thpok deficient; squares, double deficient).
(B) On the top, contour plots show expression of CD69 versus CD40L after 3 hr activation of wild-type CD4+ and CD8+ splenocytes, or of CD8+ splenocytes from
B2m–/– mice that were Thpok deficient or double deficient; on the bottom, thymocytes from the same mice were analyzed in the same assay for expression of
TCRb versus CD40L. Scatter plots on right summarizes all four experiments; symbol code is shown below graphs on the left, and bars depict mean ± SEM.
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Thpok and LRF Promote Helper T Cell Differentiationvery few CD4+ cells but harbored a large subset of CD4+CD8+
T cells (Figure 4A). These cells were absent in mice lacking both
Thpok and I-Ab (Zbtb7b–/– H2-Ab1–/–), indicating that they were
MHC II restricted (Figure 4B); accordingly, their number was not
affected by b2 m disruption. The siLP CD4+CD8+ subset was
absent in double-deficient mice (Figure 4C, left), and the number
of remaining MHC II-restricted CD4–CD8+ cells was diminished
(Figure 4C, right). As in the spleen, there were CD4+CD8– cells
in the siLP of double-deficient mice, and they did not develop in
a competitive setting (Figure S4E). Thus, Thpok and LRF redun-
dantly promote the differentiation of siLP Th effector cells.
Expression of cytokines and effector transcription factors are
key attributes of Th cells in the siLP (Zhu et al., 2010; O’Shea
and Paul, 2010). Although both Th (CD4+) and cytotoxic (CD8+)
subsets normally produce IFN-g, cytotoxic cells generally do
not express IL-17, a cytokine essential for the integrity of the
gut mucosal barrier (Klatt and Brenchley, 2010), or the transcrip-
tion factor RORgt (Zhou and Littman, 2009) (Figure 4D, left two
columns) . In addition, only CD4+ cells normally express Foxp3,
the key regulator of Treg cell differentiation (Zheng and Ruden-
sky, 2007; Belkaid and Tarbell, 2009). Expression of these
effector genes defined Thpok-deficient CD4+CD8+ cells as Th
cells, given that they included subsets expressing IL-17 or
RORgt, or Foxp3 (Figure 4D, third column). In contrast, the cyto-
kine production of the few CD4–CD8+ double-deficient cells was
dominated by IFN-g, a cytokine normally produced by cells of
either lineage, and they failed to expressed Foxp3 and RORgt
(Figure 4D, right column). Of note, the siLP Th cell compartment
was not affected by deleting LRF only (Figures S3D and S3E).
These experiments suggested that Thpok and LRF redundantly
control the development of CD4+ helper responses in vivo.
To further evaluate the potential of LRF-dependent (Thpok-
deficient) Th cells in vivo, we assessed their contribution to
siLP effector responses in a competitive setting. We generated
mixed bone marrow chimeras by reconstituting lethally irradi-626 Immunity 37, 622–633, October 19, 2012 ª2012 Elsevier Inc.ated B2m–/– recipients with a mix of B2m–/– Thpok-deficient
and -sufficient progenitors. Remarkably, Thpok-deficient siLP
effectors were only modestly outcompeted by wild-type cells,
as the ratio of mutant to competitor T cells was similar in the
spleen and siLP (Figures 5A and 5B). Thus, LRF efficiently
supports helper responses in vivo.
LRF Supports Th1 and Treg, but Not Th2 Cell
Differentiation
Although these analyses showed that LRF supported Th1, Th17,
or Treg cell differentiation, they did not assess whether LRF-
dependent cells could actually suppress or mount Th2 cell
responses against extracellular parasites. To address the first
issue, we examined whether Thpok-deficient Treg cells inhibited
the proliferation of wild-type effectors in vitro. We did not detect
any difference between wild-type and Thpok-deficient Treg cells
in these assays, demonstrating that LRF enables in vitro-
suppressive functions (Figure 5C).
Responses to extracellular parasites were of particular interest
because Runx3, expressed in LRF-dependent Th cells (Fig-
ure 1D), inhibits expression of the Th2 cell cytokine IL-4 (Naoe
et al., 2007; Djuretic et al., 2007). To examine Th2 cell responses,
we challenged Thpok-deficient mice with the intestinal helminth
Heligmosomoides polygyrus (Behnke et al., 2009), which nor-
mally generates a strong IL-4 and IL-13 response by CD4+ Th2
effector cells (Figure 6A). Thpok-deficient mice failed to control
the parasite, leading to inflammation, disruption of mucosal
architecture, and increased parasite fecundity as assessed by
egg counts (Figure 6B). Accordingly, Thpok-deficient siLP
T cells predominantly produced IFN-g (Figure 6A). It was
possible that inappropriate Runx3 expression inhibited the Th2
differentiation of Thpok-deficient cells; alternatively, it was
possible that intrinsic properties of Thpok, not shared by
LRF, were required for Th2 cell differentiation, or that LRF was
not expressed in Th2-differentiating cells. Excluding the latter
Figure 4. LRF Promotes Th Effector Cell Differentiation
(A and B) Contour plots show CD4 versus CD8 expression on TCRb+ siLP cells from (A) Zbtb7b+/+ or Zbtb7b–/– or (B) Zbtb7b–/– B2m–/– or Zbtb7b–/– H2-Ab1–/–
animals. Bottom panels depict numbers of Zbtb7b+/+ (open circles) and Zbtb7b–/– (filled circles) T cells from the indicated subset.
(C) Numbers of siLP T cells in B2m–/– mice that were Thpok deficient or Thpok and LRF double deficient. Bars (A–C) indicate average ± SEM.
(D) Contour plots show IFN-g versus IL-17A (top), TCRb versus Foxp3 (middle), and TCRb versus RORgt (bottom) on gated TCRb+ siLP cells from control, Thpok-
deficient, and Thpok and LRF double-deficient animals. Numbers within or near boxes indicate percent of cells within that box. Data are representative of at least
three experiments for each panel.
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and Thpok-deficient (CD8+) cells cultured in conditions that
promote Th2 cell differentiation (Figure S5). We could examine
the role of inappropriate Runx3 expression in vitro because
Thpok-deficient MHC II-restricted cells produced substantially
less IL-4 than their wild-type counterparts, even in ‘‘Th2-differen-
tiating’’ cultures (Figure 6C). We found that retroviral transduc-
tion of a dominant negative version of Runx3 (‘‘Runt’’), which
inhibits Runx functions (Wang et al., 2008a), restored their Th2
differentiation, increasing IL-4 and reducing IFNg production
(Figure 6D). Thus, Thpok preserves the Th2 potential of Th cells
by constraining Runx3 expression.
Thpok-Deficient Animals Mount Effective Responses
to Leishmania major
The impaired H. polygyrus response raised the possibility that
LRF-dependent Th cells, although effective under steady-stateconditions, were unable to orchestrate an orderly immune
response during an acute infectious challenge. To address this
possibility, we examined the responses of Thpok-deficient
mice to Leishmania major, an intracellular parasite normally
controlled by MHC II-restricted effectors whose differentiation
requires CD40L (Campbell et al., 1996; Kamanaka et al., 1996).
We found little or no difference between Thpok-deficient and
control animals after L. major inoculation. The clinical evolution
was similar in both genotypes (Figure 7A), characterized by the
appearance and resolution of a small lesion on the injected
ear, matching the stereotypical L. major response in mice with
intact Th cell functions (Belkaid et al., 2000). The same was
true of parasite loads at the end of the observation period (Fig-
ure 7B), demonstrating an efficient immune response. At the
lesion site, we observed the IFN-g-producing Th1 effectors
that control infection in L. major resistant strains (Wang et al.,
1994). However, although these cells were all CD4+ in controlImmunity 37, 622–633, October 19, 2012 ª2012 Elsevier Inc. 627
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Figure 5. LRF-Dependent T Cells Are Functionally Fit and Have Regulatory Function
(A and B) Lethally irradiated Zbtb7b+/+B2m–/– mice carrying both CD45.1 and CD45.2 alleles were reconstituted with a 1:1 mix of Zbtb7b+/+B2m–/– (CD45.1) and
Zbtb7b–/–B2m–/– (CD45.2) bonemarrow (A, bottom schematic). Eight weeks after reconstitution, spleen (A) and siLP (B) cells were analyzed by flow cytometry for
expression of CD45 alleles, TCRb, I-A/I-E, CD4 and CD8. Two-parameter plots (top) of CD45.1 versus CD45.2 on gated T cells (TCRb+ I-A/I-E–) or non-T cells
(TCRb– I-A/I-E+) define donor-derived populations. T cell populations were further analyzed for CD4 and CD8 expression (bottom). Numbers in graphs represent
percent of cells in gates. Data are representative of four separate bone marrow transplantation experiments (three experimental and three control animals each),
two of which were with B2m-sufficient donors.
(C) Plot shows percentage of proliferating effector cells in a 3 day in vitro suppression assay with sorted CD4+CD25+ cells from wild-type (open circles) or
Zbtb7b–/– (filled circles) mice. Plain and dashed lines depict two distinct experiments.
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Thpok and LRF Promote Helper T Cell Differentiationmice, they had the CD4+CD8+ phenotype characteristic of MHC
II-specific responders in Thpok-deficient mice (Figure 7C).
Foxp3+ Treg cells, which restrain the Th1 response (Belkaid
et al., 2002; Suffia et al., 2006), were also present at the infected
ear in Thpok-deficient mice and most of them expressed CD4
(Figure 7C). We conclude that Thpok-deficient cells orchestrate
Th cell responses in vivo.
In summary (Figure S6), the present study demonstrates that
the transcription factors Thpok and LRF redundantly promote
Th cell differentiation, and that, contrary to the current paradigm,
Thpok-deficient MHC II-restricted cells have Th cell functions.
DISCUSSION
Although the emergence of helper and cytotoxic T cell functions
is coupled to CD4+ and CD8+ T cell lineage differentiation in
the thymus, what preprograms thymocytes into either functional
fate has long remained unclear. In CD8+ T cell lineage cells, the
transcription factor Runx3 both represses Cd4 expression
(Taniuchi et al., 2002; Woolf et al., 2003) and promotes cytotoxic
gene expression (Cruz-Guilloty et al., 2009). CD4+ cells have so
far evaded a similar analysis, in part because they can adopt
multiple effector cell fates defined by the expression of specific
cytokines or transcription factors (O’Shea and Paul, 2010; Zhu
et al., 2010). Although the transcriptional circuitries that direct
differentiation into each of these fates are increasingly well
understood (O’Shea and Paul, 2010; Zhu et al., 2010), whether
a common transcriptional program underpins Th cell functions628 Immunity 37, 622–633, October 19, 2012 ª2012 Elsevier Inc.has remained unclear. Our study identifies such an activity and
demonstrates that it relies on the distinct and partly redundant
function of two transcription factors, Thpok and the related
protein LRF.
Although it was presumed that Thpok would be essential for
Th cell functions because it is required for CD4+ T cell differenti-
ation, this hypothesis had never been evaluated. In fact, we
found Thpok dispensable for many features of Th cell differenti-
ation, as well as for Foxp3 expression and the acquisition of
suppressive properties. Rather, the combined and partly redun-
dant activities of Thpok and LRF form a critical node in the tran-
scriptional circuits that enable Th cell differentiation. Such a role
for LRF was unexpected. This transcription factor is involved in
early hematopoietic differentiation, mature B cell differentiation,
and it is also needed for oncogenic cell transformation (Sakurai
et al., 2011; Maeda et al., 2009; Maeda et al., 2007). Distinct
mechanisms are involved in these previously reported functions,
including repression of the antiapoptotic protein Bim or Notch
signaling or interference with p53 function, none of which is
expected to account for LRF or Thpok function in Th cell
differentiation.
Thymocytes lacking Thpok and Runx activities adopt a CD4-
like phenotype (Egawa and Littman, 2008), suggesting that
Thpok promotes Th cell differentiation by repressing Runx3.
However, we found that cells lacking Thpok but having normal
Runx activity undergo Th cell differentiation. Thus,Runx3 repres-
sion is not required for Th cell differentiation per se; rather, it is
necessary to preserve specific effector fates (including Th2)
Figure 6. LRF Does Not Support Th2 Cell Differentiation
(A) Contour plots show IL-4 versus IL-13 and IFN-g versus IL-17A expression in siLP T cells from H. polygyrus-infected animals.
(B) Numbers of eggs in animals analyzed in (A). Data in (A) and (B) are representative of two separate infection experiments, one with three Zbtb7bfl/flCd4-Cre and
three controls the second with three Zbtb7b–/– animals and three controls.
(C) Contour plots show IFN-g versus IL-4 expression on effectors obtained from sorted naive Zbtb7b+/+ CD4+ (left) or CD8+ (middle) LN cells or CD4–CD8+ cells
from B2m–/–Zbtb7b–/– mice (right panel) after a 4 day culture in Th2 cell conditions. The plot on the right is a summary of those results.
(D) IFN-g versus IL-4 expression is shown on activated Zbtb7bfl/fl Cd4-Cre B2m–/– CD8+CD4– LN cells activated as in (C) and transduced at day 1 with a Runx3-
dominant negative (Runt) or control (empty) retrovirus; data are gated on transduced (GFP+) cells. Data in (C) and (D) are representative of at least three
experiments. Bars indicate average ± SEM. Significance was determined by a paired t test.
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toxic differentiation (Cruz-Guilloty et al., 2009), Runx3 inhibits
Th2 and promotes Th1 cell differentiation in CD4+ T cells, notably
by repressing IL-4 and promoting IFN-g expression (Djuretic
et al., 2007; Naoe et al., 2007). Runx3 is normally expressed in
Th1 effectors, but not in resting CD4+ T cells or Th2 effectors,
and it is because LRF fails to restrain Runx3 expression that
LRF does not support Th2 cell differentiation. These observa-
tions highlight the importance, for MHC II-restricted cells, to
repress the cytotoxic differentiation program directed by
Runx3. Although it could conceivably be beneficial for these cells
to maintain helper-cytotoxic bipotency, we show that restraining
Runx3 expression is essential for preserving their IL-4 produc-
tion potential. Future studies will determine whether the distinc-
tive functions of Thpok and LRF result from intrinsic differences
in their biochemical activities, for instance the recruitment of
corepressor molecules (Beaulieu and Sant’Angelo, 2011), or
from their different levels or patterns of expression.
Thpok and LRF do not act by promoting the generation of
MHC II-restricted cells in the thymus, but by enabling expression
of Th effector genes. It is possible that these factors contribute to
induce Th cell genes in MHC II-restricted thymocytes. Alterna-
tively, Thpok and LRF could serve to maintain helper loci in an
active configuration, by protecting them from transcriptionalrepression or silencing (Wildt et al., 2007; Muroi et al., 2008;
Sakaguchi et al., 2010). In this alternative scenario, Th cell
gene expression would be initiated in MHC II-restricted thymo-
cytes independently of Thpok and LRF. Instead, it would rely
on a distinct set of transcription factors required early during
CD4+ T cell differentiation, including Gata3, Tox, or E proteins
E2A and HEB, all of which are notably needed for Thpok expres-
sion (Pai et al., 2003; Jones and Zhuang, 2007; Wang et al.,
2008b; Aliahmad and Kaye, 2008; Jones-Mason et al., 2012;
Xiong and Bosselut, 2012).
Such a ‘‘maintenance’’ function for Thpok and LRF would
agree with evidence that Thpok is not required in the earliest
phases of CD4+ T cell lineage differentiation (Egawa and Littman,
2008; Wang et al., 2008b). It would also account for the apparent
paradox that LRF, despite being expressed at similar levels in
CD4+ and CD8+ cells, does not promote Th cell functions in
the latter. Indeed, only MHC II-signaled thymocytes would
initiate expression (or epigenetic opening) of Th cell loci; LRF
or Thpok would then maintain these loci in an active configura-
tion in mature CD4+ T cells. In contrast, such ‘‘priming’’ of Th
cell loci would not happen in MHC I-restricted thymocytes, pre-
venting LRF from promoting helper gene expression in CD8+
cells. It is also conceivable that additional cofactors, specifically
expressed in MHC II-restricted cells, have a permissive effectImmunity 37, 622–633, October 19, 2012 ª2012 Elsevier Inc. 629
Figure 7. LRF Supports Th Cell Responses In Vivo
(A) Evolution of ear lesions in L. major-infected Zbtb7bfl/fl Cd4-Cre (filled circles) or Zbtb7bfl/fl animals (open circles).
(B) Numbers of ear parasites in animals in (A) at 8 weeks.
(C) Top contour plots define IFN-g and Foxp3-expressing populations in T cells from infected ears, which were analyzed for CD4 and CD8 expression (bottom
row). Data in all panels are representative of two separate experiments, one (shown here) on Zbtb7bfl/fl Cd4-Cre, the other on Zbtb7b–/– and wild-type controls
with two animals per group. Bars indicate average ± SEM.
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possibilities.
Our study emphasizes that Th cell gene expression has
a strong antigen-induced component. AlthoughCd40lg is known
to be responsive to antigen stimulation (Roy et al., 1993), there is
evidence that this is also the case for Zbtb7b and for a so far
unidentified cis-regulatory element within Cd4 (Wang et al.,
2008a; Park et al., 2010; Chong et al., 2010). This raises the
possibility that the induction of Th cell genes in MHC II- but not
MHC I-restricted cells is the result of an asymmetry in antigenic
signals (in this case self-MHC peptide) during CD4-CD8+ T cell
lineage differentiation in the thymus. This hypothesis fits with
the concept that longer or stronger antigen activation signals
are required for CD4+ than for CD8+ cell differentiation (Singer
et al., 2008).
Future studies will determine how Thpok and LRF maintain Th
cell loci open. In addition to Runx3, which is not normally
expressed by naive CD4+ T cells, other factors contribute to
repress Cd4 or Zbtb7b. These include Runx1, required for
CD4+ cell survival, AP-4, Mazr, and Bcl11b (Egawa et al., 2007;
Egawa and Littman, 2011; Sakaguchi et al., 2010; Kastner
et al., 2010). It is possible that Thpok and LRF counteract such
repression by binding to Th cell loci, as has been shown of Thpok
for its own gene, Zbtb7b, and for Cd4 (Muroi et al., 2008). An
additional, nonmutually exclusive possibility is that, given that
both Thpok and LRF are thought to serve as transcriptional
repressors, they repress so far unknown repressors of Th cell
genes (Wildt et al., 2007).
One unexpected twist of our findings is the dissociation
between resting T cell phenotype and effector potential:
Thpok-deficient cells exit the thymus and colonize lymphoid
organs as CD4–CD8+, yet they express Th cell genes upon acti-
vation. This demonstrates that functional differentiation of
thymocytes can be uncoupled from their lineage choice as
defined by coreceptor expression. This observation is reminis-
cent of the re-expression of CD4 by activated human CD8+
T cells (Flamand et al., 1998; Yang et al., 1998). Conversely,
studies in nonhuman primates have shown that MHC630 Immunity 37, 622–633, October 19, 2012 ª2012 Elsevier Inc.II-restricted cells can adopt a variant CD4–CD8+ surface
phenotype, a mechanism that appears to allow these cells to
escape infection by Simian immunodeficiency virus (Beaumier
et al., 2009). In line with these observations, we considered
the possibility that a subset of mouse MHC II-restricted cells
could normally fail to sustain Thpok expression and differen-
tiate into ‘‘helper’’ CD8+ cells. However, analyses in Zbtb7b+/+
B2m–/– mice have so far failed to support that idea (data not
shown).
In summary, we have identified a bifunctional transcriptional
node that includes the transcription factors Thpok and LRF
and promotes Th cell gene expression in MHC II-restricted cells.
It serves to repress CD8+ T cell lineage genes, including Runx3,
a function carried by Thpok, and to maintain Th cell genes in an
open configuration, a function for which Thpok and LRF are
partly redundant.
EXPERIMENTAL PROCEDURES
Mice
Zbtb7b–/–, Zbtb7bfl, Runx3tRFP, and Zbtb7afl mice (Wang et al., 2008b; Wang
et al., 2008a; Zamisch et al., 2009; Maeda et al., 2007) were previously
described. H2-Ab1–/–, B2m–/–, and Cd4-Cre animals (Grusby et al., 1991;
Zijlstra et al., 1990; Lee et al., 2001) were from Taconic; CD45.1 and CD45.2
C57BL/6 animals were from the National Cancer Institute Animal Production
Facility. All transgenic mice were heterozygous for the transgene they carry.
Mice were housed in specific pathogen-free facilities and analyzed between
6–16 weeks of age unless described otherwise. Animal procedures were
approved by relevant NIH Animal Care and Use Committees.
Bone Marrow Chimeras
T-depleted (Pan T Dynal kit, Invitrogen) bone marrow was isolated from CD45
disparate animals, mixed at a 1:1 ratio, and injected into lethally irradiated (900
rads) recipients heterozygous for CD45.1 and CD45.2.
Antibodies
The following antibodieswere from either BDPharMingen or eBioscience: TCR
(H57-597), CD4 (RM4.4 or GK1.5), CD8a (53-6.7), CD24 (M1/69), CD44 (IM7),
CD69 (H1.2F3), IFN-g, IL-13, IL-4, and CD45.1 (A20); CD45.2 (104), CD8b
(53-5.8, used for all siLP staining), CD40L (MR1), Foxp3 (FJK-16S), IL-
17A, RORgt (AFKJS9), and LRF (13E9). Anti H3K4Me3 was from Millipore
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Thpok and LRF Promote Helper T Cell Differentiation(#17-614). The anti-Runx antibody was from Epitomics (# 2593-1). Immuno-
blotting analyses were performed as described (Wang et al., 2008b).
Cell Preparation and Staining
Lymph node, thymus, spleen, siLP, and ear cells were prepared and stained
according to previously described procedures (Wang et al., 2008b; Wang
et al., 2008a; Sun et al., 2007). Flow cytometry data were acquired on LSR II
or LSR Fortessa cytometers (BD Biosciences) and analyzed with FlowJo
(TreeStar) software. Dead cells and doublets were excluded by DAPI and
a combination of forward light scatter height and width gating. Enumeration
of I-Ab-2W binding cells was performed as described (Moon et al., 2007).
For CD40L expression analyses, splenocytes or LN cells were first purified
with a Dynal T negative isolation kit (Invitrogen); thymocytes and purified
T cells were then cultured in 10% FCS supplemented RPMI 1640 medium in
presence or absence of PMA (15 ng/mL) and ionomycin (300 ng/mL) at 37C
for 3 hr prior to staining. Analyses of intracellular cytokine expression were per-
formed as described (Wang et al., 2008a). Transcription factor expression was
detected with the eBioscience Foxp3 Staining Buffer Set (#00-5523) in accor-
dancewith themanufacturer’s instructions, except forRORgt andLRFstaining,
duringwhich the cellswere permeabilized overnight. TheBDCytofix/Cytoperm
kit (#554714) was used for intracellular stains in retrovirally infected cells. Dead
cells were excluded with Invitrogen’s LIVE/DEAD fixable UV kit (#L-23105).
In Vitro T Cell Analyses
Sorted naive (CD44lo) LN and spleen cells were activated and cultured as
described (Wang et al., 2008a), and restimulated for cytokine expression anal-
yses for 6 hr before staining. siLP cells were stimulated (PMA/ionomycin with
GolgiStop) in RPMI supplemented with 10% FCS, 1% Pen/Strep/Glu, 1%
NEAA, 1% sodium pyruvate, and 1X 2-mercaptoethanol for 4.5 hr. Retroviral
transductions were performed as previously described (Wang et al., 2008a).
For suppression assays, flow-sorted CD4+CD8-CD25+ cells from Zbtb7b/
or control Zbtb7b+/+ animals (2 3 104) were mixed at indicated ratios with
CFSE-treated CD45.1+ Zbtb7b+/+ CD4+CD25-CD44lo ex vivo T cells and incu-
bated in a 96-well plate for 72 hr in 1 mg/mL anti-CD3 and T cell-depleted irra-
diated splenocytes.
Infections
Mice were orally infected with 200 H. polygyrus infective larvae (L3 stage)
prepared as previously described (Wilson et al., 2005) with an oral gavage
needle. Infected mice were analyzed 28 days later. Cells were prepared as re-
ported (Sun et al., 2007), with additional shaking in EDTA (2mM) supplemented
medium prior to the first stirring incubation.
L. major infections were performed as described (Suffia et al., 2006) with 53
104 L. major clone V1 metacyclic promastigotes by intradermal ear injection.
Skin lesions were measured weekly for 8 weeks, and animals were subse-
quently euthanized. Cells were harvested from the infected ear and parasite
loads determined as described (Belkaid et al., 1998).
Chipseq and Data Analysis
MHC I- andMHC II-restricted CD8 LN T cells were purified from Zbtb7b+/+ and
B2m–/– Zbtb7b–/–, respectively, with the mouse CD8-negative isolation kit
(Dynal, Invitrogen, #114.15D, #114.17D). Chipseq was performed on micro-
coccal nuclease-digested chromatin from 5–10 million cells as described
(Wei et al., 2009). Thirty-six basepair sequence reads were acquired on an
Illumina Genome Analyzer II in accordance with the manufacturer’s protocol
in the NCI sequencing facilities. CD4 cell data was fromWei et al. (2009). Anal-
yses of Chipseq data were performed essentially as described (Wei et al.,
2009) and with Python scripts written in the laboratory. Similar results were ob-
tained with the Chipseq analysis feature of Partek Genomic Suite.
Statistical Analyses
Statistical analyses were performed with Prism (GraphPad Software, Inc.).
Significance was determined with a two-tailed Student’s t test.
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